Unbiased AI-powered news
1 stories related to this topic, newest first.
The IndependentGivinostat will become available to around 530 eligible patients in England with Duchenne muscular dystrophy following a commercial agreement between its manufacturer and NHS England. The National Institute for Health and Care Excellence confirmed the decision after the company r…